This regimen is being evaluated in the SUDOCU clinical trial, sponsored by PanACEA. Trial began in 2021.
Regimen
Sutezolid, Bedaquiline, Delamanid, & Moxifloxacin
Compounds in Regimen
Description
Trial Associations
Developer Associations